The Department of Defense offers the Amyotrophic Lateral Sclerosis Therapeutic Idea Award to support innovative research in the early stages for potential breakthroughs in ALS treatment. This grant encourages high-risk/high-reward projects with the aim of making critical discoveries and advancements in ALS therapeutics. Applicants are expected to propose well-formulated, testable hypotheses with strong scientific rationale. The closing date for applications is July 24, 2012.
Opportunity ID: 150933
General Information
| Document Type:: | Grants Notice |
| Funding Opportunity Number:: | W81XWH-12-ALSRP-TIA |
| Funding Opportunity Title:: | DoD Amyotrophic Lateral Sclerosis Therapeutic Idea Award |
| Opportunity Category:: | Discretionary |
| Opportunity Category Explanation:: | |
| Funding Instrument Type:: | |
| Category of Funding Activity:: | Science and Technology and other Research and Development |
| Category Explanation:: | |
| Expected Number of Awards:: | 1 |
| Assistance Listings Number(s):: | 12.420 — Military Medical Research and Development |
| Cost Sharing or Matching Requirement:: | No |
| Version:: | Synopsis 2 |
| Posted Date:: | Mar 08, 2012 |
| Last Updated Date:: | Mar 08, 2012 |
| Original Closing Date for Applications:: | Jul 24, 2012 |
| Current Closing Date for Applications:: | Jul 24, 2012 |
| Archive Date:: | Aug 23, 2012 |
| Estimated Total Program Funding:: | $ 640,000 |
| Award Ceiling:: | $ |
| Award Floor:: | $ |
Eligibility
| Eligible Applicants:: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
| Additional Information on Eligibility:: |
Additional Information
| Agency Name:: | Dept. of the Army — USAMRAA |
| Description:: | The Therapeutic Idea Award is designed to promote new ideas that are still in the early stages of development with the potential to yield highly impactful data and new avenues of investigation for novel therapeutics for ALS treatment. This mechanism supports conceptually innovative, high-risk/high-reward research that could ultimately lead to critical discoveries or major advancement in ALS therapeutics. Research projects should include a well-formulated, testable hypothesis based on strong scientific rationale. |
| Link to Additional Information:: | |
| Grantor Contact Information:: | If you have difficulty accessing the full announcement electronically, please contact: |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
| Synopsis 2 | Updated title | Mar 08, 2012 |
| Synopsis 1 |
Package Status
Below are CLOSED Opportunity Package(s) no longer available for this Funding Opportunity:
Package No: 1
| Assistance Listings: | 12.420 |
| Competition ID: | |
| Competition Title: | |
| Opportunity Package ID: | PKG00103651 |
| Opening Date: | Mar 08, 2012 |
| Closing Date: | Jul 24, 2012 |
| Agency Contact Information:: | 301-682-5507; help@cdmrp.org |
| Who Can Apply:: | Organization Applicants |
| mendatory_forms |
SF424 (R & R) [V1.2] Project/Performance Site Location(s) [V1.4] Research & Related Budget [V1.1] Research And Related Senior/Key Person Profile (Expanded) [V1.2] Attachments [V1.1] |
| optional_forms | R & R Subaward Budget Attachment(s) Form 5 YR 30 ATT [V1.2] |
Packages
| Assistance Listings | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions | Who Can Apply: | |
|---|---|---|---|---|---|---|---|---|
| 12.420 | PKG00103651 | Mar 08, 2012 | Jul 24, 2012 | View | 301-682-5507; help@cdmrp.org | Organization Applicants |